Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Fuxiang Sitai Medical

Request full access

Biomedical tissue engineering using silk fibroin biomaterials.

Suzhou Shi, ChinaFounded 2020Biotech & Life Sciences

About Fuxiang Sitai Medical

Fuxing Sitai Medical Technology, operating as Favorsun, is a company focused on the application of silk fibroin biomaterials in biomedical tissue engineering and repair. The firm has achieved significant scale, being the first in China to reach ton-scale production of high-purity, high molecular weight silk fibroin. This has enabled the low-cost, large-scale, and stable production of silk fibroin solutions and powders, addressing previous challenges in storage and transportation. The company's core technology, developed through a collaboration with Fudan University, centers on its ability to precisely control the molecular weight of silk fibroin. This allows for the customization of the material's performance to meet various clinical demands. Favorsun has developed proprietary technologies for producing high molecular weight silk fibroin raw material with batch-to-batch consistency, fabricating precision microspheres with uniform particle size, and creating a silk fibroin microsphere-gel composite system with tunable degradation and sustained-release capabilities. The company was a key contributor to the formulation of the Chinese industry standard YY/T 1950-2024 for "Tissue Engineering Medical Devices – Silk Fibroin". Favorsun's product applications are primarily in the fields of medical devices and medical materials, with a focus on biomedical tissue repair and an exploration of the consumer healthcare and medical aesthetics market. This includes the development of products like injectable long-acting dermal fillers based on silk fibroin hydrogel microspheres. The company has secured a medical device production license from the NMPA (National Medical Products Administration), marking its transition from laboratory research to market production.

Source: Dealroom company data

Fuxiang Sitai Medical in the Suzhou Shi ecosystem

Live from Dealroom

The Fuxiang Sitai Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Herui Venture Capital
  • Mingfeng Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Suzhou Shi HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Fuxiang Sitai Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Fuxiang Sitai Medical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.